Exp Clin Endocrinol Diabetes 2011; 119(8): 463-466
DOI: 10.1055/s-0031-1271668
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Glucose Homeostasis Abnormalities Assessed by an OGTT in Coronary Artery Disease Patients During Admission and Follow-up at Ambulation

J. Ilany1 , L. Michael2 , O. Cohen1 , S. Matetzky3 , M. Gorfine4 , H. Hod2 , A. Karasik1
  • 1Institute of Endocrinology, Sheba Medical Center, Tel-Hashomer, Israel
  • 2Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel
  • 3Heart Institute, ICCU, Sheba Medical Center, Tel-Hashomer, Israel
  • 4Faculty of Industrial Engineering and Management, Technion – Israel Institute of Technology, Haifa, Israel
Further Information

Publication History

received 15.11.2010 first decision 19.12.2010

accepted 12.01.2011

Publication Date:
03 March 2011 (online)

Abstract

Background: Most non diabetic patients admitted with acute coronary syndrome (ACS) demonstrate an abnormality in glucose homeostasis. It was claimed that an oral glucose tolerance test (OGTT) undertaken during the admission is a good indicator of the patient's glycemic status.

Aim: The aim of this study was to examine the reproducibility of OGTT based dysglycemic diagnosis during the acute admission and during an ambulatory visit in patients with ischemic heart disease (IHD).

Methods: We have repeated an OGTT on 29 patients with IHD who had been tested with OGTT during hospitalization for ACS.

Results: In 20 of the 29 (69%) patients the OGTT results improved on the repeated ambulatory test. This improvement was evident in the post-prandial glucose level yet not in the fasting levels. There were no significant differences in beta-cell function or in insulin sensitivity between the OGTTs as assessed by HOMA calculations. However there was tendency for improvement in insulin sensitivity at 2 h when assessed by the SI120 formula.

Conclusions: In this pilot study we found that impaired post-prandial glucose control in patients with ACS improves when retested at ambulation. Therefore, it is probably better to perform the OGTT as an ambulatory test and not during the acute admission for defining abnormalities in glucose homeostasis of patients with ACS.

References

  • 1 Avignon A, Boegner C, Mariano-Goulart D. et al . Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state.  International Journal of Obesity. 1999;  23 512-517
  • 2 Bartnik M, Rydén L, Ferrari R. et al . The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart.  European Heart Journal. 2004;  25 1880-1890
  • 3 Cavalot F, Petrelli A, Traversa M. et al . Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study.  Journal of Clinical Endocrinology and Metabolism. 2006;  91 813-819
  • 4 Choi KM, Lee KW, Kim SG. et al . Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus.  Journal of Clinical Endocrinology and Metabolism. 2005;  90 175-180
  • 5 Davidson MB. Counterpoint: The oral glucose tolerance test is superfluous.  Diabetes Care. 2002;  25 1883-1884
  • 6 Gerstein HC. Dysglycaemia: a cardiovascular risk factor.  Diabetes Research and Clinical Practice. 1998;  40 (suppl) S9-S14
  • 7 Ilany J, Marai I, Cohen O. et al . Glucose abnormalities in cardiac intensive care unit patients.  Acta Diabetologica. 2009;  46 209-216
  • 8 Ko GT, Chan JC, Woo J. et al . The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.  Annals of Clinical Biochemistry. 1998;  35 62-67
  • 9 Kosiborod M, Rathore SS, Inzucchi SE. et al . Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.  Circulation. 2005;  111 3078-3086
  • 10 McAlister FA, Majumdar SR, Blitz S. et al . The relation between hyperglycemia and outcomes in 2 471 patients admitted to the hospital with community-acquired pneumonia.  Diabetes Care. 2005;  28 810-815
  • 11 McCowen KC, Malhotra A, Bistrian BR. Stress-Induced hyperglycemia.  Critical Care Clinics. 2001;  17 107-124
  • 12 Mooy JM, Grootenhuis PA, de Vries H. et al . Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.  Diabetologia. 1996;  39 298-305
  • 13 Norhammar A, Tenerz Å, Nilsson G. et al . Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.  Lancet. 2002;  359 2140-2144
  • 14 Ramachandran A, Chamukuttan S, Immaneni S. et al . High incidence of glucose intolerance in Asian-Indian subjects with acute coronary syndrome.  Diabetes Care. 2005;  28 2492-2496
  • 15 Rathmann W, Icks A, Haastert B. et al . Undiagnosed diabetes mellitus among patients with prior myocardial infarction.  Zeitschrift für Kardiologie. 2002;  91 620-625
  • 16 Srinivas-Shankar U, Somauroo JD, Delduca AM. et al . Temporal change in glucose tolerance in non-ST-elevation myocardial infarction.  Diabetes Research and Clinical Practice. 2008;  82 310-316
  • 17 Tai ES, Goh SY, Lee JJM. et al . Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.  Diabetes Care. 2004;  27 1728-1734
  • 18 Tenerz Å, Norhammar A, Silveira A. et al . Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.  Diabetes Care. 2003;  26 2770-2776
  • 19 Tominaga M, Eguchi H, Manaka H. et al . Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata diabetes study.  Diabetes Care. 1999;  22 920-924

Correspondence

Dr. J. IlanyMD 

Institute of Endocrinology

Sheba Medical Center

Tel-Hashomer

52621 Israel

Phone: +972/3/5305 382

Phone: +972/5/2385 2461

Fax: +972/3/6357 018

Email: jacob.ilani@sheba.health.gov.il

    >